This week, the Federal Trade Commission halted its lawsuit against pharmacy-benefit managers CVS Caremark (CVS), Express Scripts (CI), and ...

The lawsuit filed last year ... Three” PBMs that are owned by CVS, Cigna and UnitedHealth, respectively — of artificially inflating the cost of insulin, driving up prices for payers and patients.

FTC Chair Andrew Ferguson is no longer recusing himself from the matter, he said two days after a leadership shakeup at the agency left the case in limbo.

Andrew Ferguson, the chair of the Federal Trade Commission, has decided to rejoin the agency’s lawsuit against ... drug middlemen. The FTC paused the litigation against CVS’ Caremark, Cigna ...

Federal Trade Commission Chair Andrew Ferguson has reversed course on his decision to recuse himself from the agency's legal ...

The U.S. Federal Trade Commission’s lawsuit against major pharmacy benefit managers, including UnitedHealth Group’s Optum, ...

The Federal Trade Commission’s lawsuit against three large pharmacy-benefit managers over insulin prices is on hold after President Trump fired two of the agency’s commissioners.

The health industry finds itself in turmoil as the Federal Trade Commission (FTC) delays its lawsuit against pharmacy-benefit manager units of UnitedHealth, Cigna, and CVS Health following ...